✦ LIBER ✦

One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice

✍ Scribed by M. Buysschaert; V. Preumont; P.R. Oriot; I. Paris; M. Ponchon; D. Scarnière; P. Selvais

Book ID: 116404916
Publisher: Masson Editeur
Year: 2010
Tongue: French
Weight: 379 KB
Volume: 36
Category: Article
ISSN: 1262-3636
DOI: 10.1016/j.diabet.2010.03.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Addition of exenatide to insulin therapy

Addition of exenatide to insulin therapy in individuals with type 2 diabetes in UK routine clinical practice

✍ Hermione C Price; Catherine Gorst; Usha Ayyagari; Jonathan Levy; Rury R Holman 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 211 KB

A1C and weight outcomes at 18 months in

A1C and weight outcomes at 18 months in patients with type 2 diabetes treated with exenatide in an ambulatory care setting

✍ C. McAdam-Marx; X. Ye; D. I. Brixner; R. Fabunmi; M. Wintle; K. S. Boye; D. Misu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

PDB5 IMPROVED TREATMENT SATISFACTION IN

PDB5 IMPROVED TREATMENT SATISFACTION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE OR INSULIN GLARGINE

✍ K Secnik; C Hayes; L Matza; S Kim; A Oglesby; N Yurgin; R Brodows; K Malley 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

One-Year Treatment With Exenatide Improv

One-Year Treatment With Exenatide Improves -Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

✍ Malloy, J. L.; Shaginian, R. M.; Deng, W.; Kendall, D. M.; Taskinen, M.-R.; Smit 📂 Article 📅 2009 🏛 American Diabetes Association 🌐 English ⚖ 353 KB

Effects of Exenatide Combined with Lifes

Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes

✍ Caroline M. Apovian; Richard M. Bergenstal; Robert M. Cuddihy; Yongming Qu; Shei 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 783 KB

Six-month outcomes on A1C and cardiovasc

Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting

✍ D. I. Brixner; C. McAdam-Marx; X. Ye; K. S. Boye; L. L. Nielsen; M. Wintle; D. M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB